SCHEMBL7976971

SCHEMBL7976971

CCCNC(=O)Nc1ccc2c(c1)c1ccccc1n2CC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.71
KDM4E B2RXH2 6/20 0.71
LMNA P02545 5/20 0.71
MEN1 O00255 5/20 0.71
KMT2A Q03164 5/20 0.71
SMN1; SMN2 Q16637 3/20 0.71
NPSR1 Q6W5P4 1/20 0.70
RORC P51449 3/20 0.66
NPY5R Q15761 5/20 0.65
ALDH1A1 P00352 4/20 0.61
HPGD P15428 4/20 0.60
RAB9A P51151 2/20 0.58
NPC1 O15118 1/20 0.58
HCRTR1 O43613 1/20 0.58
PAX8 Q06710 1/20 0.58
POLB P06746 1/20 0.58
MAPK1 P28482 1/20 0.58
BLM P54132 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
GAA P10253 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4729996 0.91 NPSR1 (0.69) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL7977240 0.90 NPSR1 (0.75) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL13179872 0.88 NPSR1 (0.65) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL4726409 0.85 NPY5R (0.62) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL13144117 0.84 NPSR1 (0.66) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL7722815 0.83 NPSR1 (1.00) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL21950067 0.83 NPSR1 (0.57) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL12602780 0.83 NPSR1 (0.60) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL4728828 0.82 NPSR1 (0.70) MAPTKDM4ELMNAMEN1KMT2A
SCHEMBL4727375 0.82 MAPT (0.73) MAPTKDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007409-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA UK LIMITED (GB) 2001-02-01 WO disclosed